Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic,, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

There’s a shortage of the weight-loss drug Wegovy (semaglutide) and compounding pharmacies have been stepping in to manufacture their own versions and fill the gap. Unfortunately, not all compounding pharmacies are the same, and some specialists fear that patients are getting dangerous or inappropriate versions of the drug.  MedShadow reached out to Dan Lynch, PharmD, Director of Regulatory Services at Symphony Pharmacy, to discuss what compounding pharmacies are and if your healthcare provider prescribes a compounded a drug, how to make sure you’re working with a reputable pharmacy that will provide safe compounded medicines. MedShadow: To start off, what is…

Read More

When MedShadow started collecting comments for its side effects of COVID-19 vaccine tracker, what quickly emerged is that COVID-19 shots are also associated with substantial arm pain. That result was so common that we published a separate article about the redness, pain and rashes that sometimes followed the jabs. In most cases, this was a typical response to the vaccine, which cleared up within a few days. Injection-site reactions, including redness and pain, were the most reported side effect in the COVID vaccine trials, affecting more than 84% of patients who received a Pfizer shot. On occasion, though, the reactions appeared…

Read More